SCHEMBL24834535

SCHEMBL24834535

CCc1nn(CC(=O)Nc2ccncn2)c(=O)c2ccc(C3CC3)nc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 5/20 0.47
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
P2RX3 P56373 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
TP53 P04637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
PDE5A O76074 3/20 0.36
ALOX15 P16050 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
POLB P06746 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
AKR1B1 P15121 1/20 0.34
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31325032 0.86 TSHR (0.41) NLRP3TSHRSMN1; SMN2HTTP2RX3
SCHEMBL24834534 0.83 NLRP3 (0.51) NLRP3TSHRSMN1; SMN2HTTP2RX3
SCHEMBL24077191 0.83 NLRP3 (0.48) NLRP3TSHRSMN1; SMN2HTTNPSR1
SCHEMBL31325030 0.82 NLRP3 (0.49) NLRP3TSHRSMN1; SMN2HTTP2RX3
SCHEMBL24834533 0.81 ALOX15 (0.54) TSHRALOX15AKR1B1
SCHEMBL24076969 0.78 ALOX15 (0.60) NLRP3TSHRSMN1; SMN2HTTNPSR1
SCHEMBL24834532 0.77 NLRP3 (0.45) NLRP3NPSR1TP53ALOX15KMT2A
SCHEMBL24076253 0.77 NLRP3 (0.52) NLRP3TSHRSMN1; SMN2HTTNPSR1
SCHEMBL24077164 0.77 NLRP3 (0.52) NLRP3TSHRSMN1; SMN2HTTNPSR1
SCHEMBL24834482 0.77 CYP2C19 (0.49) TSHRSMN1; SMN2HTTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023275230-A1 5-OXO-PYRIDO[2,3-D]PYRIDAZIN-6(5H)-YL ACETAMIDES JANSSEN PHARMACEUTICA NV (BE) 2023-01-05 WO disclosed